Fig. 2From: Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similarH&E stained sections of PTs (a) PT with Tils 1% (b) PT with Tils 10% (c) PT with Tils 30%Back to article page